Coeliac disease genetic risk factor IVD, kit, nucleic acid technique (NAT)
United Kingdom·In Vitro Diagnostic Device·LACAR MDX Technologies S.A.·Registered Nov 26, 2024- Device ID
- 193175
- MHRA Reference Number
- 193175
- Date Registered
- Nov 26, 2024
- Last Updated
- Oct 31, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- Coeliac disease genetic risk factor IVD, kit, nucleic acid technique (NAT)
- Type
- IVD General
- Address
- Liège Science Park Rue des Chasseurs Ardennais, 10 Liège, Belgium
- Created Date
- Dec 17, 2021
- Relationship Type
- UK Responsible Person
- Address
- 49 Greek Street London, England, United KingdomPostcode: W1D 4EG
Devices with a matching generic name or device type registered with MHRA
Additional devices represented by Qserve Group UK, Ltd. in the UK
Coeliac disease genetic risk factor IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 193175. The device is manufactured by LACAR MDX Technologies S.A. from Belgium, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Qserve Group UK, Ltd. .
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.